BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15661156)

  • 21. Role of the serine-threonine kinase PAK-1 in myxoma virus replication.
    Johnston JB; Barrett JW; Chang W; Chung CS; Zeng W; Masters J; Mann M; Wang F; Cao J; McFadden G
    J Virol; 2003 May; 77(10):5877-88. PubMed ID: 12719581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying viral propagation in vitro: toward a method for characterization of complex phenotypes.
    Duca KA; Lam V; Keren I; Endler EE; Letchworth GJ; Novella IS; Yin J
    Biotechnol Prog; 2001; 17(6):1156-65. PubMed ID: 11735454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IFN-alpha-inducing capacity of Sendai Virus in human leukocytes is independent from the hemagglutinating and hemolytic activities and from the viral proteins of the Sendai Virus preparations.
    Mattana P; Scapol L; Silvestri S; Viscomi GC
    J Biol Regul Homeost Agents; 1999; 13(4):201-6. PubMed ID: 10703943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus.
    Werden SJ; McFadden G
    Biochim Biophys Acta; 2008 Jan; 1784(1):228-37. PubMed ID: 17905673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized.
    Wang F; Barrett JW; Ma Y; Dekaban GA; McFadden G
    J Virol; 2009 Jun; 83(11):5928-32. PubMed ID: 19297474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-beta is required for interferon-alpha production in mouse fibroblasts.
    Erlandsson L; Blumenthal R; Eloranta ML; Engel H; Alm G; Weiss S; Leanderson T
    Curr Biol; 1998 Feb; 8(4):223-6. PubMed ID: 9501984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.
    Strayer DS; Cabirac G; Sell S; Leibowitz JL
    J Natl Cancer Inst; 1983 Jul; 71(1):91-104. PubMed ID: 6306326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M135R is a novel cell surface virulence factor of myxoma virus.
    Barrett JW; Sypula J; Wang F; Alston LR; Shao Z; Gao X; Irvine TS; McFadden G
    J Virol; 2007 Jan; 81(1):106-14. PubMed ID: 17065210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hTERT extends the life of human fibroblasts without compromising type I interferon signaling.
    Smith MC; Goddard ET; Perusina Lanfranca M; Davido DJ
    PLoS One; 2013; 8(3):e58233. PubMed ID: 23472163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon production and sensitivity in passaged human embryonic fibroblasts.
    Dowjat K; Plachcińska J; Zakrzewski K
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):725-33. PubMed ID: 4451440
    [No Abstract]   [Full Text] [Related]  

  • 31. Subcellular localization and antiviral activity of carminic acid/poly r(A-U) combinations.
    Krabill K; Jamison JM; Gilloteaux J; Summers JL
    Cell Biol Int; 1993 Oct; 17(10):919-34. PubMed ID: 8287022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Viral Replication by Cellular Replicative Senescence.
    Kim JA; Seong RK; Shin OS
    Immune Netw; 2016 Oct; 16(5):286-295. PubMed ID: 27799874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting single cell interferon-beta production using a fluorescent reporter telomerase-immortalized human fibroblast cell line.
    Hare DN; Subapanditha MK; Mossman KL
    STAR Protoc; 2021 Jun; 2(2):100436. PubMed ID: 33912845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relative stability of pathogenic power of infectious myxoma virus].
    JACOTOT H; VALLEE A; VIRAT B
    Ann Inst Pasteur (Paris); 1955 Feb; 88(2):234-7. PubMed ID: 13403275
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid droplet density alters the early innate immune response to viral infection.
    Monson EA; Crosse KM; Das M; Helbig KJ
    PLoS One; 2018; 13(1):e0190597. PubMed ID: 29293661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
    Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
    PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae).
    Afonso PP; Silva PM; Schnellrath LC; Jesus DM; Hu J; Yang Y; Renne R; Attias M; Condit RC; Moussatché N; Damaso CR
    J Virol; 2012 May; 86(9):5039-54. PubMed ID: 22345477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
    Ventoso I; Berlanga JJ; Almendral JM
    J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.
    Grekova S; Zawatzky R; Hörlein R; Cziepluch C; Mincberg M; Davis C; Rommelaere J; Daeffler L
    J Virol; 2010 Jan; 84(1):516-31. PubMed ID: 19864388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic and chemical adjuvants in tumor virotherapy.
    Alvarez-Breckenridge C; Kaur B; Chiocca EA
    Chem Rev; 2009 Jul; 109(7):3125-40. PubMed ID: 19462957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.